Biologics And Biosimilars Market Size And Share

  • Report Code : TIPRE00008228
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Marktgröße und Marktanteil von Biologika und Biosimilars bis 2025–2031

Buy Now

Biologics and Biosimilars Market Report Biologics and Biosimilars Market Scope and Analysis Biologics and Biosimilars Market Size and Share

Biologics and Biosimilars Market Report Analysis

Biologics and Biosimilars Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Pfizer Inc.
  • Intas Pharmaceuticals Ltd.
  • Biocon
  • Dr. Reddys Laboratories Ltd.
  • Sandoz International GmbH (Novartis division)
  • CELLTRION INC.
  • Amgen Inc.
  • STADA Arzneimittel AG
  • Apotex Inc.

Regional Overview

  • Nordamerika
  • Europa
  • Asien-Pazifik
  • Süd- und Mittelamerika
  • Naher Osten und Afrika

Market Segmentation

By Produkt
  • Rekombinante glykosylierte Proteine
  • Rekombinante nicht-glykosylierte Proteine
By Indikation
  • chronische Krankheiten
  • Onkologie
  • Autoimmunerkrankungen
  • Infektionskrankheiten
  • Bluterkrankungen
  • Wachstumshormonmangel
  • Sonstiges
By Geographie
  • Nordamerika
  • Europa
  • Asien-Pazifik
  • Süd- und Mittelamerika